EHA Webcast & Video Podcast of the 13th Congress of the European Hematology Association powered by - MULTIWEBCAST - State-of-the-art Webcast Services

SIGN IN | REGISTER NOW! | INVITATION CODE

13th Congress of the European Hematology Association

WELCOME

LIST OF PRESENTATIONS

ABOUT EHA-CME ACCREDITED PRESENTATIONS

OTHER WEBCASTS

Webcasted Presentations

BROWSE BY:

ALL PRESENTATIONS AT A GLANCE

EHA-CME ACCREDITED PRESENTATIONS

PODCAST/VODCAST

Use this index to quickly access speakers by name.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

View all the presentations from an individual speaker by finding his/her name in the alphabetical listing below.

A

G. Agnelli
	Prophylaxis and treatment of venous thromboembolism in cancer patients 2008-06-13 - English to be announced!

S. Amadori
	New agents for the treatment of acute myeloid leukemia 2008-06-13 - English to be announced!

B

G. Barosi
	Management of primary myelofibrosis 2008-06-13 - English to be announced!

S. Boehrer
	Pathogenesis and therapeutic targets in myelodysplastic syndromes 2008-06-13 - English

Niels Borregaard
	Opening Address 2008-06-13 - English

C. Brunstein
	Immunological and clinical aspects of double cord blood transplants 2008-06-13 - English

J. Bussel
	Management of immune thrombocytopenic purpura in adults 2008-06-13 - English

C

M. Cattaneo
	Congenital platelet disorders 2008-06-13 - English

D

R. Dalla Favera
	Molecular pathogenesis of B cell lymphomas 2008-06-14 - English

Michael Deininger
	The role of new agents in the management of chronic myeloid leukemia 2008-06-13 - English

R. Delwel
	Gene expression profiling to distinguish acute myeloid leukemia subtypes: discovery of a novel subtype with unique molecular and biological features 2008-06-13 - English to be announced!

A. Dispenzieri
	Impact of serum free light chain evaluation in monoclonal gammopathy 2008-06-13 - English

J. Drach
	Clinical implications of genetic abnormalities in myeloma 2008-06-13 - English to be announced!

H. Döhner
	Genetic profiling and its impact on treatment of acute myeloid leukemia 2008-06-13 - English to be announced!

E

S. Ehl
	Autoimmune neutropenia 2008-06-13 - English

T. Enver
	Stem cells in pre leukemia and leukemia 2008-06-15 - English

Marieke Essers
	IFN-A Promotes Proliferation of Dormant HSCs in vivo, Making Them Susceptible to Elimination by Chemotherapy 2008-06-14 - English

F

T. Facon
	Frontline treatment in multiple myeloma patients ineligible for stem cell transplantation 2008-06-13 - English to be announced!

W. Fibbe
	Welcome to the 13th congress of EHA 2008-06-13 - English

W. Fibbe
	Introduction to EHA Webcast 2008-06-12 - English

B. Furie
	Microparticles, thrombosis and cancer 2008-06-15 - English

G

R. Galanello
	New advances in iron chelation 2008-06-13 - English to be announced!

R. Galanello
	Mutation in TMPRSS6, a Suppressor of Hepcidin Gene Expression, in Familial Iron Deficiency Anemia 2008-06-14 - English to be announced!

P. Ghia
	Clues on the origin and behaviour of chronic lymphocytic leukemia cells 2008-06-13 - English

John Goldman
	Chronic myeloid leukemia - yesterday, today and tomorrow 2008-06-13 - English

S. Gore
	Defining the role of epigenetic therapy in myelodysplastic syndromes 2008-06-13 - English

M. Greaves
	Relationship between academia and pharma 2008-06-14 - English

N. Gökbuget
	Risk-adapted therapy of acute lymphoblastic leukemia 2008-06-13 - English to be announced!

H

M. Hallek
	Chronic lymphoid leukemia - current concepts of molecular pathogenesis and therapy 2008-06-15 - English

H. Heslop
	Cellular therapy to rebuild immunity after stem cell transplantation 2008-06-13 - English

I

P. Imbach
	Immunopathogenesis, immunomodulation and management of immune thrombocytopenic purpura in children 2008-06-13 - English

J. Ingerslev
	Treatment of bleeding disorders with pro-hemostatic drugs 2008-06-13 - English to be announced!

S. Izraeli
	Unique Activating Mutations of JAK2 in The Acute Lymphoblastic Leukemias of Down Syndrome -Biological And Therapeutic Applications 2008-06-14 - English

J

J. Jurlander
	Prognostic markers in chronic lymphocytic leukemia 2008-06-13 - English

K

E. Kimby
	Treatment of Waldenstroem macroglobulinemia 2008-06-13 - English to be announced!

L

A. List
	Immunomodulatory drugs (IMiDs) in myelodysplastic syndromes: long-term outcome 2008-06-13 - English

H. Lokhorst
	Allogeneic transplants and immune intervention in multiple myeloma 2008-06-13 - English

L. Luzzatto
	New insights into paroxysmal nocturnal haemoglobinuria 2008-06-13 - English to be announced!

M

Elizabeth Macintyre
	Molecular pathogenesis of acute lymphoblastic leukemia: an IG/TCR-centric view 2008-06-13 - English to be announced!

G. Martinelli
	Imatinib resistance: the role of BCR-ABL dependent and BCR-ABL independent mechanisms in the loss of response to tyrosine kinase inhibitors 2008-06-13 - English

C. Mecucci
	Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships 2008-06-13 - English

G. Merlini
	Advances in AL amyloidosis 2008-06-13 - English to be announced!

R. Mesa
	Blastic transformation in myeloproliferative disorders: science and therapy 2008-06-13 - English to be announced!

P

E. Papadaki
	Chronic idiopathic neutropenia: clinical and pathophysiologic aspects 2008-06-13 - English

R. Pieters
	Genes and proteins mediating drug resistance in acute lymphoblastic leukemia 2008-06-13 - English

S. Proctor
	Hodgkin lymphoma in the elderly: current status and future directions 2008-06-13 - English

R

D. Re
	Biology of Hodgkin lymphoma 2008-06-13 - English

G. Reaman
	Using novel targeted drug therapy for front-line management of pediatric acute leukemia 2008-06-13 - English

F. Rickles
	Hemostasis and cancer 2008-06-13 - English

F. Rodeghiero
	Evaluation of the severity of bleeding disorders 2008-06-13 - English to be announced!

S

G. Salles
	Treating diffuse large B-cell lymphoma: optimizing the use of anti-CD20 antibodies 2008-06-13 - English

J. San Miguel
	Treatment of relapsed multiple myeloma 2008-06-13 - English to be announced!

J. San-Miguel
	Superior Efficacy With Bortezomib Plus Melphalan–Prednisone (VMP) Versus Melphalan–Prednisone (MP) Alone In Previously Untreated Multiple Myeloma (MM): Results of The Phase III MMY-3002 Vista Study 2008-06-14 - English to be announced!

M. Schrappe
	Characteristics and management of patients with very high risk childhood acute lymphoblastic leukemia 2008-06-13 - English

P. Soothill
	Current aspects of the clinical management of hemolytic disease of the newborn and fetus 2008-06-13 - English